A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rivaroxaban-D4 | CAS 1132681-38-9 - Request Quote

Picture of Rivaroxaban-D4

Rivaroxaban-D4

SZ CAT No:SZ-R017D01
CAS No
1132681-38-9
Mol.F.
C19H14D4ClN3O5S
Mol.Wt.
439.9
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Rivaroxaban-D4 is chemically 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl-d4]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide. Rivaroxaban-D4 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban-D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1132681-38-9

Purchase 1132681-38-9

Order 1132681-38-9

Enquire 1132681-38-9

price of 1132681-38-9

1132681-38-9 Supplier

1132681-38-9 Manufacturer

1132681-38-9 Exporter

buy high quality Rivaroxaban-D4

Purchase Rivaroxaban-D4

Rivaroxaban-D4 suppliers

Rivaroxaban-D4 manufacturers

Rivaroxaban-D4 price

Order Rivaroxaban-D4

Enquire Rivaroxaban-D4

Rivaroxaban-D4 cost

Rivaroxaban-D4 Supplier

Rivaroxaban-D4 Distributor

Rivaroxaban-D4 for Method Validation

Rivaroxaban Reference Standard

Rivaroxaban-D4 for ANDA Filing

Rivaroxaban-D4 for Forced Degradation Studies

Rivaroxaban-D4 Identification Standards

Rivaroxaban-D4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,